This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1977 Mar;10(3):509-20.

doi: 10.1016/0049-3848(77)90160-8.

Disordered "fibrinolytic potential" in coronary heart disease

I D Walker, J F Davidson, I Hutton, T D Lawrie

PMID: 854883
DOI: 10.1016/0049-3848(77)90160-8

Disordered "fibrinolytic potential" in coronary heart disease

I D Walker et al. Thromb Res. 1977 Mar.

. 1977 Mar;10(3):509-20.

doi: 10.1016/0049-3848(77)90160-8.

Authors

I D Walker, J F Davidson, I Hutton, T D Lawrie

PMID: 854883
DOI: 10.1016/0049-3848(77)90160-8

No abstract available

PubMed Disclaimer

Similar articles

[Blood fibrinolytic activity following exercise in patients with primary hyperlipoproteinemia and patients with coronary artery disease].
Berent H. Berent H. Pol Arch Med Wewn. 1977 Apr;57(4):271-9. Pol Arch Med Wewn. 1977. PMID: 859745 Polish. No abstract available.
Impairment of the diurnal fibrinolytic response in man. Effects of aging, type IV hyperlipoproteinemia, and coronary artery disease.
Rosing DR, Redwood DR, Brakman P, Astrup T, Epstein SE. Rosing DR, et al. Circ Res. 1973 Jun;32(6):752-8. doi: 10.1161/01.res.32.6.752. Circ Res. 1973. PMID: 4715196 No abstract available.
Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease.
Haviar V, Riecanský L, Kusá O, Luknárová O. Haviar V, et al. Cor Vasa. 1972;14(3):188-96. Cor Vasa. 1972. PMID: 4344417 No abstract available.
[Blood coagulation and fibrinolysis in ischemic heart disease. The relationship to risk factors].
Andreenko GV, Belokon' NA, Zabotina ON, Karabasova MA. Andreenko GV, et al. Nauchnye Doki Vyss Shkoly Biol Nauki. 1988;(1):5-19. Nauchnye Doki Vyss Shkoly Biol Nauki. 1988. PMID: 3282549 Review. Russian.
[Helsinki Heart Study].
Sekiya M, Ishibashi S. Sekiya M, et al. Nihon Rinsho. 2001 Mar;59 Suppl 3:404-9. Nihon Rinsho. 2001. PMID: 11347103 Review. Japanese. No abstract available.

See all similar articles

Cited by

Hypercoagulability and coronary artery disease.
O'Connor NT, Cederholm-Williams S, Copper S, Cotter L. O'Connor NT, et al. Br Heart J. 1984 Dec;52(6):614-6. doi: 10.1136/hrt.52.6.614. Br Heart J. 1984. PMID: 6542421 Free PMC article.
Achieving Optimal Reperfusion without Adjunctive Antithrombotic Therapy: Novel Thrombolytic Dosing Strategies.
Becker RC. Becker RC. J Thromb Thrombolysis. 1995;1(3):269-277. doi: 10.1007/BF01060736. J Thromb Thrombolysis. 1995. PMID: 10608004
High PAI activity with correlation to triglyceride and HDL cholesterol values in patients with coronary artery disease with no difference in survivors of myocardial infarction.
Ihnken K, Speiser W, Ruf W, Thiel W, Schlepper M, Müller-Berghaus G. Ihnken K, et al. Ann Hematol. 1993 Nov;67(5):237-44. doi: 10.1007/BF01715054. Ann Hematol. 1993. PMID: 8241347
Protein C values in coronary artery disease.
O'Connor NT, Broekmans AW, Bertina RM. O'Connor NT, et al. Br Med J (Clin Res Ed). 1984 Nov 3;289(6453):1192. doi: 10.1136/bmj.289.6453.1192. Br Med J (Clin Res Ed). 1984. PMID: 6437481 Free PMC article. No abstract available.
Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
Aznar J, Estellés A, Tormo G, Sapena P, Tormo V, Blanch S, España F. Aznar J, et al. Br Heart J. 1988 May;59(5):535-41. doi: 10.1136/hrt.59.5.535. Br Heart J. 1988. PMID: 3132963 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science